Registry for Eosinophilic Gastrointestinal Disorders (REGID)

Overview

Develop Registry tool

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Other
  • Study Primary Completion Date: December 2016

Detailed Description

The purpose of this research study is to develop a registry tool used for the management and care of patients with eosinophilic disorders, and create a research resource that will provide further insights into these disorders.

Clinical Trial Outcome Measures

Primary Measures

  • Registry Aim
    • Time Frame: Open-ended
    • The registry will allow for the standardization of care while also allowing us to identify gaps in care that need to be addressed and areas for future research at Cincinnati Children’s Hospital Medical Center (CCHMC) and collaborating sites around the nation.

Participating in This Clinical Trial

Inclusion Criteria

  • Eosinophilic Gastrointestinal Disorder diagnosis

Gender Eligibility: All

Minimum Age: 1 Year

Maximum Age: 12 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Children’s Hospital Medical Center, Cincinnati
  • Collaborator
    • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Marc E. Rothenberg, MD, PhD, Principal Investigator, Children’s Hospital Medical Center, Cincinnati

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.